Successful treatment of carcinomatous meningitis with gefitinib in a patient with lung adenocarcinoma harboring a mutated EGF receptor gene.

Successful treatment of carcinomatous meningitis with gefitinib in a patient with lung adenocarcinoma harboring a mutated EGF receptor gene.

Item
http://www.wikidata.org/entity/Q46622914
Advances in treatment of brain metastases from primary non-small cell lung cancerComparison of Gefitinib versus VMP in the combination with radiotherapy for multiple brain metastases from non-small cell lung cancer.Clinical significance of gefitinib antitumor activity in patients with lung adenocarcinoma.Efficacy of the irreversible ErbB family blocker afatinib in epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI)-pretreated non-small-cell lung cancer patients with brain metastases or leptomeningeal disease.Blood-brain barrier permeability of gefitinib in patients with brain metastases from non-small-cell lung cancer before and during whole brain radiation therapy.Evaluation on efficacy and safety of tyrosine kinase inhibitors plus radiotherapy in NSCLC patients with brain metastases.Recurrent response to advanced lung adenocarcinoma with erlotinib developing leptomeningeal metastases during gefitinib therapy and two case reports.Pharmacokinetic Properties of Anticancer Agents for the Treatment of Central Nervous System Tumors: Update of the Literature.Combined action of EGFR tyrosine kinase inhibitors and whole-brain radiotherapy on EGFR-mutated non-small-cell lung cancer patients with brain metastasis.EGFR mutation status in brain metastases of non-small cell lung carcinoma.Headaches in brain tumor patients: primary or secondary?Intratumoral modeling of gefitinib pharmacokinetics and pharmacodynamics in an orthotopic mouse model of glioblastomaFavorable response to icotinib in a lung cancer patient with a special mutation at exon 19 of epidermal growth factor receptor.Leptomeningeal metastasis from solid tumors: a single center experience in Chinese patients.Clinical Efficacy of Afatinib Treatment for a Patient with Leptomeningeal Carcinomatosis.Factor associated with failure to administer subsequent treatment after progression in the first-line chemotherapy in EGFR-mutant non-small cell lung cancer: Okayama Lung Cancer Study Group experience.Erlotinib efficacy and cerebrospinal fluid concentration in patients with lung adenocarcinoma developing leptomeningeal metastases during gefitinib therapy.
P2860

Successful treatment of carcinomatous meningitis with gefitinib in a patient with lung adenocarcinoma harboring a mutated EGF receptor gene.

Item
http://www.wikidata.org/entity/Q46622914
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Successful treatment of carcin ...... g a mutated EGF receptor gene.
@en
Successful treatment of carcin ...... g a mutated EGF receptor gene.
@nl
type
label
Successful treatment of carcin ...... g a mutated EGF receptor gene.
@en
Successful treatment of carcin ...... g a mutated EGF receptor gene.
@nl
prefLabel
Successful treatment of carcin ...... g a mutated EGF receptor gene.
@en
Successful treatment of carcin ...... g a mutated EGF receptor gene.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Successful treatment of carcin ...... g a mutated EGF receptor gene.
@en
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P921